Cx Institutional Incyte Corp Transaction History

Cx Institutional

$2.87 Billion
Q2 2025

A detailed history of Cx Institutional transactions in Incyte Corp stock. As of the latest transaction made, Cx Institutional holds 4,271 shares of INCY stock, worth $376,488. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,271

Previous 4,271 -0.0%

Holding current value

$376,488

Previous $291,000 -0.0%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	BUY	$55.17 - $71.22 $22,674 - $29,271	411 Added 10.65%	4,271 $291,000
Q1 2025 Apr 15, 2025	SELL	$60.0 - $75.26 $2,520 - $3,160	-42 Reduced 1.08%	3,860 $234,000
Q4 2024 Jan 21, 2025	BUY	$65.08 - $83.38 $34,817 - $44,608	535 Added 15.89%	3,902 $269,000
Q3 2024 Oct 11, 2024	SELL	$57.33 - $68.61 $1,662 - $1,989	-29 Reduced 0.85%	3,367 $222,000
Q2 2024 Jul 11, 2024	BUY	$51.18 - $63.75 $173,807 - $216,495	3,396 New	3,396 $205,000
Q4 2023 Jan 12, 2024	BUY	$52.16 - $64.19 $175,727 - $216,256	3,369 New	3,369 $211,000
Q2 2022 Aug 02, 2022	BUY	$66.18 - $83.18 $33,950 - $42,671	513 New	513 $39,000
Q4 2021 Jan 18, 2022	SELL	$63.34 - $74.11 $4,560 - $5,335	-72 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$68.67 - $84.02 $28,223 - $34,532	-411 Reduced 85.09%	72 $5,000
Q2 2021 Aug 04, 2021	BUY	$79.87 - $87.53 $10,702 - $11,729	134 Added 38.4%	483 $41,000
Q1 2021 Apr 15, 2021	BUY	$76.02 - $100.5 $5,701 - $7,537	75 Added 27.37%	349 $28,000
Q4 2020 Jan 12, 2021	BUY	$80.74 - $97.7 $4,763 - $5,764	59 Added 27.44%	274 $24,000
Q3 2020 Oct 13, 2020	BUY	$85.07 - $109.69 $5,954 - $7,678	70 Added 48.28%	215 $19,000
Q2 2020 Aug 06, 2020	BUY	$74.18 - $108.93 $4,005 - $5,882	54 Added 59.34%	145 $15,000
Q1 2020 Apr 29, 2020	SELL	$63.18 - $85.97 $11,561 - $15,732	-183 Reduced 66.79%	91 $7,000
Q4 2019 Jan 21, 2020	BUY	$73.04 - $95.72 $1,899 - $2,488	26 Added 10.48%	274 $24,000
Q3 2019 Oct 10, 2019	SELL	$72.82 - $86.52 $1,602 - $1,903	-22 Reduced 8.15%	248 $18,000
Q2 2019 Jul 17, 2019	SELL	$73.52 - $88.7 $15,365 - $18,538	-209 Reduced 43.63%	270 $23,000
Q1 2019 Apr 03, 2019	BUY	$63.56 - $88.17 $28,538 - $39,588	449 Added 1496.67%	479 $41,000
Q4 2018 Jan 14, 2019	BUY	$58.5 - $69.94 $643 - $769	11 Added 57.89%	30 $2,000
Q2 2018 Jul 12, 2018	BUY	$60.85 - $83.98 $1,156 - $1,595	19 New	19 $2,000

Others Institutions Holding INCY

# of Institutions

738

Shares Held

203M

Call Options Held

516K

Put Options Held

265K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $19.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Incyte Corp Transaction History